IFNA1 and COVID-19: hsa-mir-26b-5p[67] and hsa-mir-26a-5p[68] are thought to modulate antiviral immune responses, particularly in TNF-α and IFN signaling pathways, while hsa-mir-98-5p[69] is frequently associated with inflammatory responses and cytokine release syndrome, potentially contributing to the pathophysiology of COVID-19.